Schwartz C C, Zech L A, VandenBroek J M, Cooper P S
Department of Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298.
J Clin Invest. 1993 Mar;91(3):923-38. doi: 10.1172/JCI116314.
Our aim was to identify and quantitate cholesterol pools and transport pathways in blood and liver. By studying bile fistula subjects, using several types of isotopic preparations, simultaneous labeling of separate cholesterol pools and sampling all components of blood and bile at frequent intervals, we developed a comprehensive multicompartmental model for cholesterol within the rapidly miscible pool. Data in six components (bile acids, esterified cholesterol in whole plasma, and free cholesterol in blood cells, bile, alpha lipoproteins, and beta lipoproteins) were modeled simultaneously with the SAAM program. The analysis revealed extensive exchange of free cholesterol between HDL and liver, blood cells, and other tissues. There was net free cholesterol transport from HDL to the liver in most subjects. The major organ that removed esterified cholesterol from blood was the liver. A large portion (4,211 mumol) of total hepatic cholesterol comprised a pool that turned over rapidly (t1/2 of 72 min) by exchanging mainly with plasma HDL and was the major source of bile acids and biliary cholesterol. Only 6% of hepatic newly synthesized cholesterol was used directly for bile acid synthesis: the analysis showed that 94% of newly synthesized cholesterol was partitioned into the large hepatic pool (putative plasma membrane free cholesterol) which exchanged rapidly with plasma lipoproteins. Bile acid synthetic rate correlated directly with the size of the large hepatic pool. In conclusion, hepatic and blood cholesterol pools and transports have been quantitated. HDL plays a central role in free cholesterol exchange/transport between all tissues and plasma. In humans, the metabolically active pool comprises a large portion of total hepatic cholesterol that, in part, regulates bile acid synthesis.
我们的目标是识别和定量血液及肝脏中的胆固醇池和转运途径。通过研究胆瘘受试者,使用多种类型的同位素制剂,同时标记不同的胆固醇池,并频繁采集血液和胆汁的所有成分样本,我们建立了一个针对快速混合池中胆固醇的综合多室模型。利用SAAM程序对六个成分(胆汁酸、全血浆中的酯化胆固醇以及血细胞、胆汁、α脂蛋白和β脂蛋白中的游离胆固醇)的数据进行了同时建模。分析显示,高密度脂蛋白(HDL)与肝脏、血细胞及其他组织之间存在广泛的游离胆固醇交换。在大多数受试者中,存在从HDL到肝脏的净游离胆固醇转运。从血液中清除酯化胆固醇的主要器官是肝脏。肝脏总胆固醇的很大一部分(4211微摩尔)构成了一个周转迅速的池(半衰期为72分钟),主要通过与血浆HDL交换,是胆汁酸和胆汁胆固醇的主要来源。肝脏新合成的胆固醇中只有6%直接用于胆汁酸合成:分析表明,94%新合成的胆固醇被分配到与血浆脂蛋白快速交换的大肝脏池中(假定为质膜游离胆固醇)。胆汁酸合成速率与大肝脏池的大小直接相关。总之,已经对肝脏和血液中的胆固醇池及转运进行了定量。HDL在所有组织与血浆之间的游离胆固醇交换/转运中起核心作用。在人类中,代谢活跃池占肝脏总胆固醇的很大一部分,部分调节胆汁酸合成。